Associations of erythrocyte membrane fatty acids with the concentrations of C-reactive protein, interleukin 1 receptor antagonist and adiponectin in 1373 men

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 91, Issue 4, 2014, Pages 169-174

  Takkunen, M J ^a   de Mello, V D F ^a   Schwab, U S ^a,b   Agren J J ^a   Kuusisto, J ^b   Uusitupa, M I J ^a,b  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

Biomarkers; C reactive protein; Erythrocyte membrane; Fatty acids; Inflammation

Indexed keywords

ACYL COENZYME A DESATURASE; ADIPONECTIN; ARACHIDONIC ACID; C REACTIVE PROTEIN; DIHOMO GAMMA LINOLENIC ACID; DOCOSAHEXAENOIC ACID; FATTY ACID; ICOSAPENTAENOIC ACID; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; LINOLEIC ACID; PALMITOLEIC ACID; VACCENIC ACID; BIOLOGICAL MARKER; MONOUNSATURATED FATTY ACID;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ERYTHROCYTE MEMBRANE; FINLAND; FINN (PEOPLE); HUMAN; MALE; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; WAIST CIRCUMFERENCE; BLOOD; INFLAMMATION; METABOLISM; MIDDLE AGED;

ADIPONECTIN; AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; ERYTHROCYTE MEMBRANE; FATTY ACIDS; FATTY ACIDS, MONOUNSATURATED; HUMANS; INFLAMMATION; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; LINOLEIC ACID; MALE; MIDDLE AGED;

EID: 84937199961     PISSN: 09523278     EISSN: 15322823     Source Type: Journal    
DOI: 10.1016/j.plefa.2014.07.005     Document Type: Article

References (43)

1. Donath M.Y., Shoelson S.E. Type 2 diabetes as an inflammatory disease. Nat. Rev. Immunol. 2011, 11:98-107.
2. Vasto S., Carruba G., Lio D., et al. Inflammation, ageing and cancer. Mech. Ageing Dev. 2009, 130:40-45.
3. Libby P. Inflammation and cardiovascular disease mechanisms. Am. J. Clin. Nutr. 2006, 83:456S-460S.
4. Aronson D., Avizohar O., Levy Y., Bartha P., Jacob G., Markiewicz W. Factor analysis of risk variables associated with low-grade inflammation. Atherosclerosis 2008, 200:206-212.
5. Calder P.C., Ahluwalia N., Brouns F., et al. Dietary factors and low-grade inflammation in relation to overweight and obesity. Br. J. Nutr. 2011, 106(Suppl 3):S5-S78.
6. Emerging Risk Factors Collaboration, Kaptoge S., Di Angelantonio E., et al. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet 2010, 375:132-140.
7. C Reactive Protein Coronary Heart Disease Genetics Collaboration (CCGC), Wensley F., Gao P., et al. Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data. Br. Med. J. 2011, 342:d548.
8. Juge-Aubry C.E., Somm E., Giusti V., et al. Adipose tissue is a major source of interleukin-1 receptor antagonist: upregulation in obesity and inflammation. Diabetes 2003, 52:1104-1110.
9. Herder C., Brunner E.J., Rathmann W., et al. Elevated levels of the anti-inflammatory interleukin-1 receptor antagonist precede the onset of type 2 diabetes: the Whitehall II study. Diabetes Care 2009, 32:421-423.
10. Pihlajamaki J., Kuulasmaa T., Kaminska D., et al. Serum interleukin 1 receptor antagonist as an independent marker of non-alcoholic steatohepatitis in humans. J. Hepatol. 2012, 56:663-670.
11. Li S., Shin H.J., Ding E.L., van Dam R.M. Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis. J. Am. Med. Assoc. 2009, 302:179-188.
12. Turer A.T., Scherer P.E. Adiponectin: mechanistic insights and clinical implications. Diabetologia 2012, 55:2319-2326.
13. Hodson L., Skeaff C.M., Fielding B.A. Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake. Prog. Lipid Res. 2008, 47:348-380.
14. Harris W.S., Pottala J.V., Sands S.A., Jones P.G. Comparison of the effects of fish and fish-oil capsules on the n 3 fatty acid content of blood cells and plasma phospholipids. Am. J. Clin. Nutr. 2007, 86:1621-1625.
15. Katan M.B., Deslypere J.P., van Birgelen A.P., Penders M., Zegwaard M. Kinetics of the incorporation of dietary fatty acids into serum cholesteryl esters, erythrocyte membranes, and adipose tissue: an 18-month controlled study. J. Lipid Res. 1997, 38:2012-2022.
16. Stancakova A., Javorsky M., Kuulasmaa T., Haffner S.M., Kuusisto J., Laakso M. Changes in insulin sensitivity and insulin release in relation to glycemia and glucose tolerance in 6,414 Finnish men. Diabetes 2009, 58:1212-1221.
17. Takkunen M., Agren J., Kuusisto J., Laakso M., Uusitupa M., Schwab U. Dietary fat in relation to erythrocyte fatty acid composition in men. Lipids 2013, 48:1093-1102.
18. Lepage G., Roy C.C. Direct transesterification of all classes of lipids in a one-step reaction. J. Lipid Res. 1986, 27:114-120.
19. Zong G., Ye X., Sun L., et al. Associations of erythrocyte palmitoleic acid with adipokines, inflammatory markers, and the metabolic syndrome in middle-aged and older Chinese. Am. J. Clin. Nutr. 2012, 96:970-976.
20. Enzenbach C., Kroger J., Zietemann V., et al. Erythrocyte membrane phospholipid polyunsaturated fatty acids are related to plasma C-reactive protein and adiponectin in middle-aged German women and men. Eur. J. Nutr. 2011, 50:625-636.
21. Sun Q., Ma J., Campos H., et al. Blood concentrations of individual long-chain n-3 fatty acids and risk of nonfatal myocardial infarction. Am. J. Clin. Nutr. 2008, 88:216-223.
22. Farzaneh-Far R., Harris W.S., Garg S., Na B., Whooley M.A. Inverse association of erythrocyte n-3 fatty acid levels with inflammatory biomarkers in patients with stable coronary artery disease: The Heart and Soul Study. Atherosclerosis 2009, 205:538-543.
23. Petersson H., Lind L., Hulthe J., Elmgren A., Cederholm T., Riserus U. Relationships between serum fatty acid composition and multiple markers of inflammation and endothelial function in an elderly population. Atherosclerosis 2009, 203:298-303.
24. Reinders I., Virtanen J.K., Brouwer I.A., Tuomainen T.P. Association of serum n-3 polyunsaturated fatty acids with C-reactive protein in men. Eur. J. Clin. Nutr. 2012, 66:736-741.
25. Matsumori R., Miyazaki T., Shimada K., et al. High levels of very long-chain saturated fatty acid in erythrocytes correlates with atherogenic lipoprotein profiles in subjects with metabolic syndrome. Diabetes Res. Clin. Pract. 2013, 99:12-18.
26. Petersson H., Basu S., Cederholm T., Riserus U. Serum fatty acid composition and indices of stearoyl-CoA desaturase activity are associated with systemic inflammation: longitudinal analyses in middle-aged men. Br. J. Nutr. 2008, 99:1186-1189.
27. Nelson D., Cox M. Lehninger: Principles of Biochemistry 2008, W.H. Freeman and Company, New York, NY.
28. Martinelli N., Girelli D., Malerba G., et al. FADS genotypes and desaturase activity estimated by the ratio of arachidonic acid to linoleic acid are associated with inflammation and coronary artery disease. Am. J. Clin. Nutr. 2008, 88:941-949.
29. Ferrucci L., Cherubini A., Bandinelli S., et al. Relationship of plasma polyunsaturated fatty acids to circulating inflammatory markers. J. Clin. Endocrinol. Metab. 2006, 91:439-446.
30. Kalogeropoulos N., Panagiotakos D.B., Pitsavos C., et al. Unsaturated fatty acids are inversely associated and n-6/n-3 ratios are positively related to inflammation and coagulation markers in plasma of apparently healthy adults. Clin. Chim. Acta 2010, 411:584-591.
31. Hirota S., Adachi N., Gomyo T., Kawashima H., Kiso Y., Kawabata T. Low-dose arachidonic acid intake increases erythrocytes and plasma arachidonic acid in young women. Prostaglandins. Leukot. Essent. Fatty Acids 2010, 83:83-88.
32. Hickling S., Hung J., Knuiman M., Divitini M., Beilby J. Are the associations between diet and C-reactive protein independent of obesity?. Prev. Med. 2008, 47:71-76.
33. van Woudenbergh G.J., Kuijsten A., Tigcheler B., et al. Meat consumption and its association with C-reactive protein and incident type 2 diabetes: the Rotterdam Study. Diabetes Care 2012, 35:1499-1505.
34. Kakutani S., Ishikura Y., Tateishi N., et al. Supplementation of arachidonic acid-enriched oil increases arachidonic acid contents in plasma phospholipids, but does not increase their metabolites and clinical parameters in Japanese healthy elderly individuals: a randomized controlled study. Lipids Health Dis. 2011, 10:241-252.
35. Johnson G.H., Fritsche K. Effect of dietary linoleic acid on markers of inflammation in healthy persons: a systematic review of randomized controlled trials. J. Acad. Nutr. Diet 2012, 112:1029-1041. (1041.e1-15).
36. Bjermo H., Iggman D., Kullberg J., et al. Effects of n-6 PUFAs compared with SFAs on liver fat, lipoproteins, and inflammation in abdominal obesity: a randomized controlled trial. Am. J. Clin. Nutr. 2012, 95:1003-1012.
37. Makhoul Z., Kristal A.R., Gulati R., et al. Associations of very high intakes of eicosapentaenoic and docosahexaenoic acids with biomarkers of chronic disease risk among Yup'ik Eskimos. Am. J. Clin. Nutr. 2010, 91:777-785.
38. Poudel-Tandukar K., Sato M., Ejima Y., et al. Relationship of serum fatty acid composition and desaturase activity to C-reactive protein in Japanese men and women. Atherosclerosis 2012, 220:520-524.
39. Mozaffarian D., Cao H., King I.B., et al. Circulating palmitoleic acid and risk of metabolic abnormalities and new-onset diabetes. Am. J. Clin. Nutr. 2010, 92:1350-1358.
40. Cao H., Gerhold K., Mayers J.R., Wiest M.M., Watkins S.M., Hotamisligil G.S. Identification of a lipokine, a lipid hormone linking adipose tissue to systemic metabolism. Cell 2008, 134:933-944.
41. Djousse L., Matthan N.R., Lichtenstein A.H., Gaziano J.M. Red blood cell membrane concentration of cis-palmitoleic and cis-vaccenic acids and risk of coronary heart disease. Am. J. Cardiol. 2012, 110:539-544.
42. Green C.D., Ozguden-Akkoc C.G., Wang Y., Jump D.B., Olson L.K. Role of fatty acid elongases in determination of de novo synthesized monounsaturated fatty acid species. J. Lipid Res. 2010, 51:1871-1877.
43. Malerba G., Schaeffer L., Xumerle L., et al. SNPs of the FADS gene cluster are associated with polyunsaturated fatty acids in a cohort of patients with cardiovascular disease. Lipids 2008, 43:289-299.